Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians

Experimental Gerontology

Volumn 39, Issue 8, 2004, Pages 1249-1252

  Pola, Roberto ^a,b   Flex, Andrea ^a   Gaetani, Eleonora ^a   Proia, Anna S ^a   Papaleo, Pierangelo ^a   Di Giorgio, Angela ^a   Straface, Giuseppe ^a   Pecorini, Giovanni ^a   Serricchio, Michele ^a   Pola, Paolo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b Lab of Vasc Biology and Genetics   (Italy)

Author keywords

Alzheimer's disease; Gene polymorphism; Inflammation; MCP 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; ITALY; LOGISTIC MODELS; MALE; POLYMORPHISM, GENETIC;

EID: 3543147237     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2004.05.001     Document Type: Article

References (22)

1. Aguilar F., Gonzalez-Escribano M.F., Sanchez-Roman J., Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens. 58:2001;335-338
2. Bothwell M., Giniger E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell. 102:2000;271-273
3. Combarros O., Infante J., Llorca J., Berciano J. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease. Neurosci. Lett. 360:2004;25-28
4. Dickson D.W., Farlo J., Davies P., Crystal H., Fuld P., Yen S.H. Alzheimer's disease double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132:1988;86-101
5. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2:2001;108-115
6. Gonzalez-Escribano M.F., Torres B., Aguilar F., Rodriguez R., Garcia A., Valenzuela A., Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum. Immunol. 64:2003;741-744
7. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., Symon L. Cerebral blood flow in dementia. Arch. Neurol. 32:1975;632-637
8. Hixons J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and clavage with HhaI. Lipid Res. 31:1990;545-548
9. Izikson L., Klein R.S., Luster A.D., Weiner H.L. Targeting monocyte recruitment in CNS autoimmune disease. Clin. Immunol. 103:2002;125-131
10. Jibiki T., Terai M., Shima M., Ogawa A., Hamada H., Kanazawa M., Yamamoto S., Oana S., Kohno Y. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum. 44:2001;2211-2212
11. Lee Y.B., Nagai A., Kim S.U. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69:2002;94-103
12. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34:1984;939-944
14. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasler W.E., Weiss T.S., Herfarth H., Lock G., Scholmerich J., Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology. 125:2003;1085-1093
15. Nussbaum M., Treves T.A., Korczyn A.D. DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia. Alz. Dis. Assoc. Disord. 6:1992;111-118
16. Pola R., Flex A., Gaetani E., Dal Lago A., Gerardino L., Pola P., Bernabei R. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population. Neuroreport. 13:2002;1645-1647
17. Pola R., Flex A., Gaetani E., Santoliquido A., Serricchio M., Pola P., Bernabei R. Intercellular adhesion molecule-1 K469E gene polymorphism and Alzheimer's disease. Neurobiol. Aging. 24:2003;385-387
18. Rovin B., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 259:1999;344-348
19. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 16:2003;136-144
20. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., Horvath L., Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis. 158:2001;233-239
21. Szalai C., Kozma G.T., Nagy A., Bojszko A., Krikovszky D., Szabo T., Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J. Allergy Clin. Immunol. 108:2001;375-381
22. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9:2003;453-457